Mixed trend on the daily chart: above its 200-day average, below its 50-day · 50-day above the 200-day · SuperTrend down since Sep 29 · below the Ichimoku cloud · RSI 26 (oversold) · MACD below its signal
| 3.44 | 52-week high | +82.49% |
| 3.25 | Previous month high | +72.41% |
| 2.33 | Previous month low | +23.61% |
| 2.14 | Previous week high | +13.53% |
| 2.07 | R3 (classic) | +10.08% |
| 2.02 | R2 (classic) | +7.32% |
| 1.97 | Previous day high | +4.56% |
| 1.95 | R1 (classic) | +3.66% |
| 1.90 | Pivot | +0.90% |
| 1.89 | Price now | |
| 1.85 | Previous day low | −1.86% |
| 1.84 | Previous week low | −2.39% |
| 1.83 | S1 (classic) | −2.76% |
| 1.78 | S2 (classic) | −5.52% |
| 1.71 | S3 (classic) | −9.18% |
| 0.8000 | 52-week low | −57.56% |
None of the 29 investors followed here reported a position in STIM in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 13, 2026 | Chernett JoreyBeneficial Owner of more than 10% of a Class of Security | Purchase at price 3.16 per share. | 14K | $44.24K |
| Jul 22, 2026 | Naor NirChief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 500K | — |
| Jul 13, 2026 | Chernett JoreyBeneficial Owner of more than 10% of a Class of Security | Purchase at price 1.78 per share. | 35K | $62.30K |
| May 27, 2026 | Muir Glenn PDirector | Stock Award(Grant) at price 0.00 per share. | 30K | — |
| May 27, 2026 | Cascella Robert ADirector | Stock Award(Grant) at price 0.00 per share. | 36.3K | — |
| May 27, 2026 | Conley Sheryl LDirector | Stock Award(Grant) at price 0.00 per share. | 30K | — |
| May 27, 2026 | Rosengarten MeganDirector | Stock Award(Grant) at price 0.00 per share. | 30K | — |
| May 27, 2026 | Cucuz SashaDirector | Stock Award(Grant) at price 0.00 per share. | 30K | — |
| May 27, 2026 | Amin Avinash N. M.D.Director | Stock Award(Grant) at price 0.00 per share. | 30K | — |
| May 18, 2026 | Chernett JoreyBeneficial Owner of more than 10% of a Class of Security | Purchase at price 1.17 per share. | 100K | $117.00K |
| May 11, 2026 | Chernett JoreyBeneficial Owner of more than 10% of a Class of Security | Purchase at price 1.34 per share. | 475K | $636.50K |
| Apr 20, 2026 | Chernett JoreyBeneficial Owner of more than 10% of a Class of Security | Purchase at price 1.51 - 1.58 per share. | 200K | $309.00K |
| Mar 29, 2026 | Chernett JoreyBeneficial Owner of more than 10% of a Class of Security | Purchase at price 1.25 per share. | 385.4K | $481.80K |
| Mar 26, 2026 | Chernett JoreyBeneficial Owner of more than 10% of a Class of Security | Purchase at price 1.35 per share. | 500K | $675.00K |
| Mar 25, 2026 | Chernett JoreyBeneficial Owner of more than 10% of a Class of Security | Purchase at price 1.40 - 1.44 per share. | 150K | $211.00K |
| Mar 22, 2026 | Reuvers Daniel LChief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 1.50M | — |
| Mar 19, 2026 | Chernett JoreyBeneficial Owner of more than 10% of a Class of Security | Purchase at price 1.41 per share. | 169.5K | $238.96K |
| Mar 18, 2026 | Chernett JoreyBeneficial Owner of more than 10% of a Class of Security | Purchase at price 1.33 - 1.35 per share. | 1.06M | $1.42M |
| Mar 18, 2026 | Sullivan Keith JFormer | Sale at price 1.34 per share. | 46.3K | $62.03K |
| Mar 18, 2026 | Macan William AndrewOfficer | Sale at price 1.34 per share. | 16K | $21.45K |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 51.4 | -35.9 | 8.2 | 33.8 | -20.6 | -15.6 | 52.3 | 43.4 | -17.6 | -19.4 | +36.6% | ||
| 2025 | 92.5 | 37.1 | -13.4 | 19.0 | -10.7 | -10.7 | 25.8 | -24.1 | -18.0 | -2.9 | -43.8 | -7.4 | −14.3% |
| 2024 | 17.2 | -11.8 | 58.7 | -29.2 | -43.0 | -6.3 | 3.9 | -52.8 | -13.9 | 35.5 | -2.9 | 61.0 | −44.5% |
| 2023 | -14.4 | -3.2 | -48.9 | -21.3 | 19.2 | -21.2 | -8.4 | -16.8 | -17.7 | -14.8 | 58.3 | 59.3 | −57.8% |
| 2022 | -19.7 | -6.7 | -9.3 | -19.5 | 9.8 | 19.8 | 29.9 | -14.4 | -10.9 | 4.7 | 88.6 | 9.4 | +54.0% |
| 2021 | 58.7 | -11.9 | -20.3 | -15.1 | 29.2 | 18.1 | -17.2 | -49.3 | -2.4 | -20.7 | -25.6 | 15.2 | −59.9% |
| 2020 | -19.2 | -20.2 | -34.7 | 32.3 | -26.8 | 5.5 | 38.3 | 119.9 | -17.2 | 1.9 | 73.9 | 29.0 | +147.4% |
| 2019 | -11.5 | 1.9 | -12.6 | 9.3 | -30.9 | 8.6 | -4.8 | -10.4 | -22.1 | 7.2 | -51.5 | 3.9 | −76.8% |
| 2018 | -6.2 | 32.5 | -3.0 | -20.5 | -30.0 | 8.5 | −27.3% |
TimeframesDown on the hourly, daily and monthly, mixed on the weekly.
under a falling 21 EMA, 21 under 50
under a falling 21 EMA, 21 under 50
pulling back under the 21 EMA
under a falling 21 EMA, 21 under 50
No member of Congress has disclosed a STIM trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Buy / hold / sell counts